SEVELAMER CARBONATE REDUCES PHOSPHATURIA BUT HAS NO EFFECT ON SERUMC-TERMINAL FIBROBLAST GROWTH FACTOR 23 LEVELS IN STAGE 3B/4 CKD PATIENTS : THE RESULTS OF A FRENCH, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROL, RANDOMIZED CLINICAL TRIAL

被引:0
作者
Liabeuf, S. [1 ,2 ]
Ryckelink, J. P. [3 ]
El Esper, N. [1 ]
Urena, P. [4 ]
Combe, C. [5 ]
Dussol, B. [6 ]
Fouque, D. [7 ]
Vanhille, P. [8 ]
Frimat, L. [9 ]
Thervet, E. [10 ]
Prie, D. [11 ]
Choukroun, G. [1 ,2 ]
机构
[1] CHU Amiens, Dept Nephrol, Amiens, France
[2] UPJV, INSERM, U1088, Amiens, France
[3] CHU Caen, Dept Nephrol, F-14000 Caen, France
[4] Clin Landy, Dept Nephrol, St Ouen, France
[5] CHU Bordeaux, Dept Nephrol, Bordeaux, France
[6] CHU Marseille, Dept Nephrol, Marseille, France
[7] Hop Edouard Herriot, Dept Nephrol, Lyon, France
[8] CH Valenciennes, Dept Nephrol, Valenciennes, France
[9] CHU Nancy, Dept Nephrol, Nancy, France
[10] CHU Paris HEGP, Dept Nephrol, Paris, France
[11] CHU Paris Necker, Dept Nephrol, Paris, France
关键词
D O I
10.1093/ndt/gfv177.8
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
FP409
引用
收藏
页数:1
相关论文
empty
未找到相关数据